8NN logo

Thor Medical DB:8NN Stock Report

Last Price

€0.078

Market Cap

€21.5m

7D

14.7%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

8NN Stock Overview

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway.

8NN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Thor Medical ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Thor Medical
Historical stock prices
Current Share Pricekr0.078
52 Week Highkr0.17
52 Week Lowkr0.064
Beta0
1 Month Change-7.38%
3 Month Change-31.51%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-53.91%

Recent News & Updates

Recent updates

Shareholder Returns

8NNDE BiotechsDE Market
7D14.7%1.2%2.5%
1Yn/a34.7%7.0%

Return vs Industry: Insufficient data to determine how 8NN performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how 8NN performed against the German Market.

Price Volatility

Is 8NN's price volatile compared to industry and market?
8NN volatility
8NN Average Weekly Movement24.7%
Biotechs Industry Average Movement5.7%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8NN's share price has been volatile over the past 3 months.

Volatility Over Time: 8NN's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2017n/aAlf Bjørsethhttps://www.thormedical.no

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.

Thor Medical ASA Fundamentals Summary

How do Thor Medical's earnings and revenue compare to its market cap?
8NN fundamental statistics
Market cap€21.49m
Earnings (TTM)-€479.79k
Revenue (TTM)n/a

0.0x

P/S Ratio

-44.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8NN income statement (TTM)
Revenuekr0
Cost of Revenuekr0
Gross Profitkr0
Other Expenseskr5.60m
Earnings-kr5.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)-0.024
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 8NN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.